Search results (64)
« Back to PublicationsInterleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
Gharahdaghi N. et al, (2026), N Engl J Med, 394, 2212 - 2222
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity.
Kronsteiner B. et al, (2025), Sci Rep, 15
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Amini A. et al, (2025), Sci Immunol, 10
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Murray SM. et al, (2025), Sci Immunol, 10
Asparagine availability controls germinal center B cell homeostasis.
Yazicioglu YF. et al, (2024), Sci Immunol, 9
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection.
Jindal J. et al, (2024), Metabolism, 161
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure, 32, 1594 - 1602.e6
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery.
Ali M. et al, (2024), Clin Exp Immunol, 218, 78 - 92
Dysregulated immunologic landscape of the early host response in melioidosis.
Rongkard P. et al, (2024), JCI Insight, 9
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med, 5
Metabolic requirements of CD160 expressing memory-like NK cells in Gram-negative bacterial infection.
Preechanukul A. et al, (2024), Clin Transl Immunology, 13
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
Murray SM. et al, (2024), J Hepatol, 80, 109 - 123
SARS-CoV-2-specific antibody and T-cell responses after COVID-19 BA.1 bivalent boosting
Kronsteiner-Dobramysl B. et al, (2024), EUROPEAN JOURNAL OF IMMUNOLOGY, 54, 423 - 423